mdlinx mdlinx
Latest (437) Full Text Articles (11295) Article Summary

Pan-Antimicrobial Failure of Alexidine as a Contact Lens Disinfectant When Heated in Bausch & Lomb Plastic Containers: Implications for the Worldwide Fusarium Keratitis Epidemic of 2004 to 2006
Eye & Contact Lens: Science and Clinical Practice, 07/11/2012

Elder B et al. – Heating of an alexidine solution in ReNu high–density polyethylene plastic containers results in the same loss of anti–Fusarium activity as reported when testing the original ReNu with MoistureLoc solution. This loss of inhibitory activity is not specific to Fusarium and occurs with other fungi and bacteria that cause keratitis. The reasons for the lack of reports of bacterial and/or non–Fusarium fungal keratitis during the original Fusarium keratitis epidemic remain unclear at this time.

► Click here to access PubMed, Publisher and related articles...
<< Previous Article | Next Article >>

    Currently, there are no available articles.

Your Unread Messages in Medical Student

See All >> Messages include industry-sponsored communications and special communications from MDLinx

Most Popular Medical Student Articles

Last month's top read Top Articles of 2012

Indexed Journals in Medical Student: Academic Medicine, BMC Medical Education, Medical Teachermore

Other Topics in Medical Student

Register now to view all the MDLinx contents (FREE)!

  • Stay current on the latest literature, research and clinical news
  • Get special communications and offers from MDLinx and our sponsors
  • Receive invitations to paid market research
View Samples and Register

Stay current - Media Tool

Newsletter
RSS
Follow Us
Facebook

Receive free subspecialty
"5-minute updates" via email

Sign up!

Send the E-mail Newsletter to a Colleague


Send

Subscribe to our free RSS feeds:
Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More

Follow Us on Twitter
Twitter is a rich source of instantly updated information. Join today and follow @MDLinx to start receiving tweets. Learn More

Close